Ipamorelin
growth-hormone
Verified
A selective growth hormone secretagogue that stimulates the pituitary gland to release growth hormone.
Chemical Information
Source:
Synthetic pentapeptide produced via solid-phase peptide synthesis.
Clinical Information
Purposes:
Increase GH production
Weight management
Anti-aging effects
Dosing:
Typical dosing is 200-300mcg per day, administered via subcutaneous injection.
Related Peptides:
CJC-1295
GHRP-2
GHRP-6
Safety Information
Side Effects:
- Water retention
- Headache
- Lethargy
Contraindications:
- Active malignancy
- Uncontrolled diabetes
- Pregnancy or breastfeeding
Research & References
- Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-61.
- https://pubmed.ncbi.nlm.nih.gov/9849822/
Last updated: 3/28/2025 at 5:16:27 AM
Version: 1
Detailed Information
Purposes
Increase GH production
Weight management
Anti-aging effects
Related Peptides
CJC-1295
GHRP-2
GHRP-6
Source Information
Synthetic pentapeptide produced via solid-phase peptide synthesis.
Last updated: March 28, 2025
Version: 1